Skip to main content
Top
Published in:

Open Access 16-05-2025 | Dementia | Neurological Update

Hearing impairment and dementia: cause, catalyst or consequence?

Authors: Benjamin A. Levett, Avinash Chandra, Jessica Jiang, Nehzat Koohi, Dale Sharrad, Lucy B. Core, Jeremy C. S. Johnson, Madison Tutton, Tim Green, Dona M. P. Jayakody, Jin-Tai Yu, Iracema Leroi, Charles R. Marshall, Doris-Eva Bamiou, Chris J. D. Hardy, Jason D. Warren

Published in: Journal of Neurology | Issue 6/2025

Login to get access

Abstract

The relationship between hearing impairment and dementia has attracted significant attention, the 2024 Lancet Commission report identifying hearing loss as the largest modifiable risk factor for dementia from mid-life. The nature of this linkage between dementia and hearing remains unclear and is likely to be complex. In principle, hearing impairment could cause (directly promote), catalyze (amplify) or be a consequence of neurodegenerative pathology and cognitive decline. Here we use this framework to examine different lines of evidence for the association between hearing impairment and dementia, and consider how this evidence speaks to potential mechanisms and treatment implications. We conclude by considering practical clinical implications for management of patients with hearing impairment and dementia, the potential role for central hearing tests as ‘auditory biomarkers’ of dementia, and the need for further collaborative and mechanistically motivated research in this area.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Hearing impairment and dementia: cause, catalyst or consequence?
Authors
Benjamin A. Levett
Avinash Chandra
Jessica Jiang
Nehzat Koohi
Dale Sharrad
Lucy B. Core
Jeremy C. S. Johnson
Madison Tutton
Tim Green
Dona M. P. Jayakody
Jin-Tai Yu
Iracema Leroi
Charles R. Marshall
Doris-Eva Bamiou
Chris J. D. Hardy
Jason D. Warren
Publication date
16-05-2025

EAN 2025

Unlock your free and exclusive access to the latest news and expert interviews from the European Academy of Neurology's annual congress.

Read more

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest